Evaxion Biotech A/S

NASDAQ: EVAX · Real-Time Price · USD
2.88
0.02 (0.70%)
At close: Aug 15, 2025, 3:59 PM
2.84
-1.39%
After-hours: Aug 15, 2025, 04:10 PM EDT

Evaxion Biotech A/S Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Nov 14, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
3.3M 3.35M 3.3M 278.37K 124.48K 73.6K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
3.3M 3.35M 3.3M 278.37K 124.48K 73.6K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-14.21M -14.72M -15.1M -19.13M -20.22M -22.23M -24.36M -24.68M -25.26M -25.27M -26.46M -26.29M -27.06M -25.83M -22.76M -21.53M -18.45M
Interest Income
2.62M 5.74M 6.28M 6.27M 6.28M 945.33K 474K 1.1M 2.6M 2.83M 3.51M 3.09M 1.59M 2.04M 1.39M 1.2M 1.17M
Pretax Income
-14.11M -11.36M -12.19M -16.03M -15.54M -22.95M -25.26M -25.3M -24.34M -23.94M -23.95M -23.7M -26.25M -24.71M -22.43M -21.34M -17.79M
Net Income
-13.34M -10.57M -11.5M -15.24M -14.73M -22.16M -24.47M -24.54M -23.62M -23.17M -24.67M -24.18M -26.23M -24.53M -20.43M -19.19M -16.01M
Selling & General & Admin
7.42M 7.31M 7.88M 8.68M 9.44M 10.37M 10.67M 9.75M 9.16M 8.21M 7.32M 6.8M 6.57M 6.26M 6.48M 6.71M 6.16M
Research & Development
9.78M 10.46M 10.52M 10.73M 10.91M 11.93M 13.69M 14.93M 16.11M 17.06M 19.14M 19.49M 20.49M 19.57M 16.27M 14.82M 12.28M
Other Expenses
302K 302K n/a n/a n/a n/a n/a n/a n/a n/a 71K 71K 71K 71K 12K 12K 12K
Operating Expenses
17.51M 18.08M 18.4M 19.4M 20.35M 22.31M 24.36M 24.68M 25.26M 25.27M 26.46M 26.29M 27.06M 25.83M 22.76M 21.53M 18.45M
Interest Expense
1.01M 856.21K 967.21K 764K 760K 840K 1.32M 1.67M 1.68M 1.51M 990K 506K 776K 915K 1.06M 1.01M 514K
Selling & Marketing Expenses
-1.45K -5.2K 287.32K 287.32K 288.76K 292.52K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
17.51M 18.08M 18.4M 19.4M 20.35M 22.31M 24.36M 24.68M 25.26M 25.27M 26.46M 26.29M 27.06M 25.83M 22.76M 21.53M 18.45M
Income Tax Expense
-762.16K -787.65K -691.1K -788.8K -814.94K -791.45K -786K -767K -719K -772K 724K 474K -18K -178K -2M -2.16M -1.78M
Shares Outstanding (Basic)
1.11M 1.07M 1.38M 1.35M 1.17M 683.39K 691.5K 676.55K 644.6K 603.49K 595.84K 580.1K 579.1K 541.78K 479.97K 473.54K 444.89K
Shares Outstanding (Diluted)
1.11M 1.07M 1.38M 1.35M 1.17M 683.39K 691.5K 676.55K 644.6K 603.49K 595.84K 596K 579.1K 541.78K 479.97K 473.54K 444.89K
EPS (Basic)
-10.8 -8.4 -11.6 -18.4 -22.2 -33 -37.6 -39.2 -39 -39.2 -43.2 -44.6 -50.8 -50 -45 -44 -37.2
EPS (Diluted)
-11.8 -8.4 -11.6 -18.4 -22.2 -33 -37.6 -39.2 -38.8 -39 -43 -44.4 -50.8 -50 -45 -44 -37.2
EBITDA
-13.17M -10.57M -9.23M -13.15M -14.24M -21.59M -23.83M -23.63M -22.68M -22.42M -23.59M -23.84M -26.14M -24.46M -21.4M -20.44M -17.38M
EBIT
-14.8M -12.2M -11.19M -15.23M -14.74M -22.07M -24.65M -24.34M -23.37M -23.14M -23.71M -23.95M -26.23M -24.55M -21.57M -20.53M -17.47M
Depreciation & Amortization
127.12K 226.87K 326.62K 437.16K 549.5K 539K 528.5K 369.75K 261K 213K 165K 150K 116.75K 83.5K 71.25K 70.33K 82.58K